機関投資家の保有一覧

Eversept Partners, LP

持ち方

—

評価額を取得中

届出上位5銘柄の比重

—

保有

115銘柄

Eversept Partners, LP は、2026年6月30日の SEC Form 13F で 115 銘柄の保有を報告しました。届出上位には United Therapeutics、Encompass Health、Ensign Group が並び、ヘルスケアにまたがります。下の銘柄名と保有株数は届出に基づきます。

届出上位の10銘柄

1
UT
UTHRUnited Therapeutics
ヘルスケア・ 287,668 株
—
2
EH
EHCEncompass Health
ヘルスケア・ 1,026,919 株
—
3
EN
ENSGEnsign Group
ヘルスケア・ 602,079 株
—
4
AB
ABVXAbivax
ヘルスケア・ 913,880 株
—
5
NT
NTRANatera
ヘルスケア・ 175,807 株
—
6
VE
VERAVera Therapeutics
ヘルスケア・ 2,212,770 株
—
7
CL
CLDXCelldex Therapeutics
ヘルスケア・ 1,785,941 株
—
8
SN
SNDXSyndax Pharmaceuticals
ヘルスケア・ 2,798,210 株
—
9
TV
TVTXTravere Therapeutics
ヘルスケア・ 798,973 株
—
10
HC
HCAHCA Healthcare
ヘルスケア・ 98,252 株
—

残り 105 銘柄をすべて見る ▾

#	銘柄	保有株数	概算評価額
11	CTRECareTrust REIT	1,072,015	—
12	BKDBrookdale Senior Living	3,396,470	—
13	PCVXVaxcyte	629,952	—
14	THCTenet Healthcare	114,199	—
15	IONSIonis Pharmaceuticals	664,684	—
16	MRNAModerna	152,122	—
17	CHEChemed	52,523	—
18	BBNXBeta Bionics	1,249,441	—
19	LLYEli Lilly	20,116	—
20	GSKGSK	481,833	—
21	GERNGeron Corporation	18,717,422	—
22	OHIOmega Healthcare Investors	483,547	—
23	CYHCommunity Health Systems	7,864,575	—
24	WELLWelltower	87,312	—
25	PODDInsulet	148,816	—
26	UNHUnitedHealth Group	51,145	—
27	LTCLTC Properties	420,640	—
28	PNTGPennant Group	460,272	—
29	VKTXViking Therapeutics	602,922	—
30	INSMInsmed	149,209	—
31	VRDNViridian Therapeutics	831,142	—
32	AMNAMN Healthcare Services	428,531	—
33	MOHMolina Healthcare	80,594	—
34	BCRXBioCryst Pharmaceuticals	1,865,653	—
35	COGTCogent Biosciences	490,235	—
36	BMRNBioMarin Pharmaceutical	249,607	—
37	RVTYRevvity	83,624	—
38	LQDALiquidia	428,652	—
39	HUMHumana	31,171	—
40	PHVSPharvaris	386,383	—
41	BRKRBruker	182,894	—
42	ASNDAscendis Pharma	41,621	—
43	CELCCelcuity	127,931	—
44	CTMXCytomX Therapeutics	3,558,497	—
45	RLAYRelay Therapeutics	434,314	—
46	PTGXProtagonist Therapeutics	58,504	—
47	CRVSCorvus Pharmaceuticals	747,994	—
48	DFTXDefinium Therapeutics	217,185	—
49	CMPSCOMPASS Pathways	672,825	—
50	REPLReplimune Group	590,252	—
51	XENEXenon Pharmaceuticals	196,532	—
52	MLYSMineralys Therapeutics	309,689	—
53	LBRXLB Pharmaceuticals	183,663	—
54	BHVNBiohaven	515,804	—
55	ELVNEnliven Therapeutics	136,631	—
56	NAMSNewAmsterdam Pharma	275,471	—
57	NVONovo Nordisk	169,227	—
58	PALIPalisade Bio	4,182,785	—
59	ARDXArdelyx	1,678,345	—
60	GPCRStructure Therapeutics	196,302	—
61	NHCNational HealthCare	22,116	—
62	PACSPACS Group	117,441	—
63	GKOSGlaukos Corporation	29,343	—
64	NHINational Health Investors	70,673	—
65	BEAMBeam Therapeutics	166,289	—
66	TARSTarsus Pharmaceuticals	55,710	—
67	SNDASonida Senior Living	102,624	—
68	ARQTArcutis Biotherapeutics	135,355	—
69	ANABAnaptysBio	69,983	—
70	PMVPPMV Pharmaceuticals	1,890,904	—
71	ANROAlto Neuroscience	128,286	—
72	AGLagilon health	37,792	—
73	ISRGIntuitive Surgical	7,241	—
74	VORVor Biopharma	149,681	—
75	RGENRepligen	14,401	—
76	ALECAlector	1,423,873	—
77	RAREUltragenyx Pharmaceutical	154,130	—
78	DSGNDesign Therapeutics	190,000	—
79	IFRXInflaRx	1,304,069	—
80	EQEquillium	1,520,824	—
81	CTNMContineum Therapeutics	148,017	—
82	IVVDInvivyd	2,237,015	—
83	SPRBSpruce Biosciences	40,000	—
84	AMRNAmarin	145,296	—
85	VIRVir Biotechnology	156,636	—
86	HELPCybin	146,403	—
87	PRQRProQR Therapeutics	1,022,265	—
88	GRCEGrace Therapeutics	772,900	—
89	SPRYARS Pharmaceuticals	377,007	—
90	RVMDRevolution Medicines	6,943	—
91	SRZNSurrozen	47,777	—
92	TECHBio-Techne	19,308	—
93	AVRAnteris Technologies	166,229	—
94	EVMNEvommune	174,460	—
95	EDITEditas Medicine	458,809	—
96	INOInovio Pharmaceuticals	1,035,360	—
97	WHWKWhiteHawk Therapeutics	303,306	—
98	ODTXOdyssey Therapeutics	49,658	—
99	SVRASavara	204,428	—
100	EYPTEyePoint Pharmaceuticals	297,735	—
101	PLRXPliant Therapeutics	891,425	—
102	ENGNenGene Holdings	469,584	—
103	BCYCBicycle Therapeutics	190,715	—
104	LPCNLipocine	294,989	—
105	RVPRetractable Technologies	580,919	—
106	ASMBAssembly Biosciences	16,510	—
107	AKBAAkebia Therapeutics	427,095	—
108	RLMDRelmada Therapeutics	93,192	—
109	SSIISS Innovations International	110,157	—
110	EHTHeHealth	404,854	—
111	KPTIKaryopharm Therapeutics	276,174	—
112	GHRSGH Research	8,672	—
113	AVTXAvalo Therapeutics	10,000	—
114	SLQTSelectQuote	319,788	—
115	ATAIATAI	102,430	—

2026年6月30日時点の SEC への Form 13F 届出 (運用資産 $100M 以上の機関投資家が四半期ごとに提出) の集計。届出は四半期末から最大45日遅れで公開されるため、現在の保有と異なる場合があります。概算評価額と構成比は当サイトの株価で計算した参考値です。届出対象外の資産 (米国外上場株・債券など) は含まれません。